Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice
Okawa et al. evaluate a fluorescent risedronate analogue, 800CW-pRIS, as a potential treatment for medication-related osteonecrosis of the jaw. The authors demonstrate an improvement in wound healing and inflammation with 800CW-pRIS pre-treatment in a mouse model of bisphosphonate-associated osteone...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Portfolio
2022-09-01
|
| Serija: | Communications Medicine |
| Online pristup: | https://doi.org/10.1038/s43856-022-00172-x |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|